<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for OGXI</title>
    <link />
    <description>Headlines for OncoGenex Pharmaceuticals</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>OncoGenex Plans Cedar Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3614905/oncogenex-plans-cedar-clinical-trial-evaluating-ogx-427-in-combination-with-chemo.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 23 May 2013 06:33:13 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex Loss Lower than Expected - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98750/oncogenex-loss-lower-than-expected.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 06 May 2013 14:28:01 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1399201-oncogenex-pharmaceuticals-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 03 May 2013 12:04:07 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex Pharmaceuticals Becomes Oversold (OGXI)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11911059/1/oncogenex-pharmaceuticals-becomes-oversold-ogxi.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 01 May 2013 12:47:00 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex to Initiate Rainier Clinical Trial Evaluating OGX-427 with ABRAXANE plus Gemcitabine</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3546953/oncogenex-to-initiate-rainier-clinical-trial-evaluating-ogx-427-with-abraxane-plu.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 01 May 2013 06:45:12 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex' OGX-427 Progresses - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96994/oncogenex-ogx-427-progresses.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 12 Apr 2013 16:50:01 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex: A Cancer Biotech Worth Betting On</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1335421-oncogenex-a-cancer-biotech-worth-betting-on.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 12 Apr 2013 13:45:15 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Lows</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3482884/stocks-hitting-52-week-lows.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 09 Apr 2013 11:31:27 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex's Second Cancer Drug Gaining Investor Attention</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1302381-oncogenex-s-second-cancer-drug-gaining-investor-attention.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 26 Mar 2013 17:51:45 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex: SYNERGY Trial Is The Major Catalyst In Sight</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1269311-oncogenex-synergy-trial-is-the-major-catalyst-in-sight.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 13 Mar 2013 07:58:49 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex Loss Lower than Expected - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94472/oncogenex-loss-lower-than-expected.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 11 Mar 2013 15:46:01 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex Pharmaceuticals Management Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1257811-oncogenex-pharmaceuticals-management-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 07 Mar 2013 19:01:40 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex Pharma Offers Update on Clinical Development Program</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3398080/oncogenex-pharma-offers-update-on-clinical-development-program.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 07 Mar 2013 16:24:54 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex' Candidate Progresses - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/92805/oncogenex-candidate-progresses.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 14 Feb 2013 16:50:01 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex Pharma Outlines Plans for Beginning Borealis-2 Clinical Trial Evaluating OGX-427 in Combin</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3325429/oncogenex-pharma-outlines-plans-for-beginning-borealis-2-clinical-trial-evaluatin.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 12 Feb 2013 08:08:27 GMT</pubDate>
    </item>
    <item>
      <title>Isis Pharma Updates on its Pipeline - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/90277/isis-pharma-updates-on-its-pipeline.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 11 Jan 2013 15:20:01 GMT</pubDate>
    </item>
    <item>
      <title>Small is beautiful, tiny is even better</title>
      <link>http://www.fool.com/news/xt/marketwatch/www.marketwatch.com/story/small-is-beautiful-tiny-is-even-better-2012-12-31.aspx?mod=247wallst&amp;source=itxwebtxt0000015</link>
      <author>MarketWatch</author>
      <pubDate>Mon, 31 Dec 2012 14:04:42 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex Announces Initiation of Randomized Phase 2 "PACIFIC" Study of OGX-427 in Combo with Zytiga</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/12/12/3186417/oncogenex-announces-initiation-of-randomized-phase-2-pacific-study-of-ogx-427-in-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 19 Dec 2012 09:33:59 GMT</pubDate>
    </item>
    <item>
      <title>Prostate Cancer Market Takes Shape - Part 2: Treatments In Clinical Development</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1035641-prostate-cancer-market-takes-shape-part-2-treatments-in-clinical-development.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 29 Nov 2012 11:53:09 GMT</pubDate>
    </item>
    <item>
      <title>OncoGenex Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/993711-oncogenex-pharmaceuticals-management-discusses-q3-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 08 Nov 2012 22:00:07 GMT</pubDate>
    </item>
  </channel>
</rss>
